Total Equity - Adaptive Biotechnologies Corp (NASDAQ:ADPT) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 3.8 USD 8.57%

Updated:

Adaptive Biotechnologies Corp
Total Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Adaptive Biotechnologies Corp
Total Equity Peer Comparison

TMO

DHR

MTD

A

IQV

Company		Total Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Adaptive Biotechnologies Corp NASDAQ:ADPT	Total Equity $274.9m	CAGR 3-Years -28%	CAGR 5-Years -1%	CAGR 10-Years N/A
	Thermo Fisher Scientific Inc NYSE:TMO	Total Equity $46.7B	CAGR 3-Years 11%	CAGR 5-Years 11%	CAGR 10-Years 11%
	Danaher Corp NYSE:DHR	Total Equity $53.4B	CAGR 3-Years 10%	CAGR 5-Years 11%	CAGR 10-Years 9%
	Mettler-Toledo International Inc NYSE:MTD	Total Equity -$158.7m	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Agilent Technologies Inc NYSE:A	Total Equity $6.2B	CAGR 3-Years 9%	CAGR 5-Years 4%	CAGR 10-Years 1%
	IQVIA Holdings Inc NYSE:IQV	Total Equity $6.1B	CAGR 3-Years 1%	CAGR 5-Years -2%	CAGR 10-Years N/A

See Also

Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Total Equity amounts to 274.9m USD.

Over the last year, the Total Equity growth was -35%. The average annual Total Equity growth rates for Adaptive Biotechnologies Corp have been -28% over the past three years , -1% over the past five years .

Join more than 137,000+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.